Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
The Newspaper Publication of Notice of loss of share certificate of the Company, published in the Financial Express English and Gujarati Editions, both on December 20, 2022. Zydus Lifesciences Ltd - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate under regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release dated December 10, 2022 titled 'Zydus receives two final approvals from the USFDA for Silodosin capsules and Pregabalin capsules'.
150k Covid-19 vaccine doses procured from Zydus Cadila: Govt in Lok Sabha
A total of 1.5 lakh Covid vaccine doses have been procured by the government from Zydus Cadila at Rs 375.90 per jab (including GST), Minister of State for Health Bharati Pravin Pawar informed the Lok Sabha on Friday. As on December 5, 2022, a total of 102.54 crore first doses and a total of 95.09 crore second doses of COVID-19 vaccine have been administered. A total of 22.29 crore precaution doses have also been administered, Pawar said in a written reply. She further said that 90 per cent of population aged 12 and above in the country have been covered by both doses of COVID-19 vaccine. Cadila Pharmaceuticals to invest 100 crore to set up formulations facility in Odisha
Cadila Pharmaceuticals has announced the investment at the recently concluded Make in Odisha Conclave Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of notice of 1st Extra Ordinary General Meeting of the financial year 2022-2023 of Zydus Lifesciences Limited published in the Financial Express English and Gujarati Editions Zydus Lifesciences Ltd - 532321 - Shareholders Meeting December 30, 2022
Shareholders meeting December 30, 2022 Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed a copy of press release dated December 2, 2022 titled Zydus receives final approval from the USFDA for Estradiol Transdermal System which will be manufactured at the Moraiya plant'. Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Topiramate Extended Release Capsules Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of two independent directors.